Adhesive Small Bowel Obstruction Surgery

The study included all adult patients operated upon for adhesive SBO in the Uppsala and Gävleborg regions (n = 402) during a 5-year period (2007–2012). Adult patients (≥18 years) operated upon for SBO were identified with procedure and diagnostic codes in the medical record systems [14 ]. In total, there were 618,614 inhabitants in the regions, comprising 6.5% of the Swedish population.
A detailed retrospective analysis of clinical outcome of surgery for the cohort has previously been reported [15 (link)]. Demographic data and clinical results from that study are given in Supplementary Tables S1 and S2.
Data on follow-up from medical records have then been re-analysed regarding outpatient visits, emergency visits, radiology, in-hospital stay, surgery, and intensive care unit (ICU)-care and are updated as of February 2022. Patients were followed to death or last note in medical records; follow-up time was calculated from day of index SBO-operation until death or last note in medical records. Patients lost to follow-up (e.g., foreigners) were included only as long as they had any documented contact with the participating hospitals. The study was approved by the local ethical committee at Uppsala University (Registration number 2015/196) and registered atClinicalTrials.gov(NCT03602352/https://clinicaltrials.gov/ct2/show/NCT03602352?cond=Small+Bowel+Obstruction&draw=3&rank=24/).